Semaglutide Medically Supervised Weight Loss Protocol
Do you want to use Semaglutide as a “tool” to help create a lasting lifestyle diet? When Semaglutide first hit the market, we were slightly skeptical about its effectiveness. However, we have been pleasantly surprised with this medication and have high hopes that it could be very useful to help treat obesity in the modern day. Treating weight issues and making positive changes to your diet and lifestyle can dramatically decrease your risk of having serious diseases as you age. We are very excited to be offering the compounded form of Semaglutide at The Natural Path and the results we have seen in MOST of our patients have been nothing short of exciting. The ideal candidate has at least 10-100+ lbs. of fat to lose and has not been able to do so with diet and exercise. This is also a great program for those with insulin resistance and strong food cravings.
Please Note: We do NOT use any of the trademarked products created by Novo Nordisk. The Semaglutide created in compounding pharmacies is NOT the same form or the same raw material that is patented by Novo Nordisk and used in their pharmaceutically branded products. This form of compounded Semaglutide has NOT been approved or tested by the FDA and is not the same form created by Novo Nordisk. It is usually a form also known as Semaglutide sodium or semaglutide acetate. Our compounding pharmacies guarantee safety and purity of this product and we have had incredible results in our patient population.
The only reason the compounding pharmacies can create this form of Semaglutide (usually semaglutide sodium or semaglutide acetate) is because the pharmaceutically branded forms are on the FDA’s shortage list. Once the pharmaceutically branded forms of Semaglutide created by Novo Nordisk are removed from the shortage list, compounding pharmacies will no longer be able to create this compounded version of Semaglutide sodium or Semaglutide acetate.
Again, we do not use or claim to use the pharmaceutically branded forms of Semaglutide or the patented version of the semaglutide molecule used by Novo Nordisk. We use a semaglutide sodium or semaglutide acetate created in our state of the art compounding pharmacy.
Anytime Semaglutide is mentioned in this website it is referring to Semaglutide acetate or Semaglutide sodium and not the patented version created by Novo Nordisk.
Semaglutide sodium and Semaglutide acetate are not FDA Approved or Tested.
Semaglutide is a glucagon-like peptide-1 FDA approved for the treatment of overweight and obesity. Weekly self-administered injections work by suppressing appetite and improving blood sugar metabolism. In June 2021, the U.S. Food and Drug Administration approved this novel weight loss drug for Americans with a BMI of 27 with a co-morbid condition or a BMI over 30. This weekly injection is the first approved drug for weight management in over 7 years and offers a safe and effective way to suppress appetite and lose weight, while learning how to create and follow a lifestyle diet. At this time, the medication can also be used “off label” for those with a BMI below 27 who have weight to lose. Semaglutide is being reviewed at this time to be FDA approved for general weight loss in the future.
How does compounded Semaglutide sodium work?
"I'm just ecstatic with the results. I've lost 22 pounds in the past 3 months, which might not sound like much to some, but for me, that's nothing short of a miracle...
The weight loss has been consistent, and it has happened with ease. Dr. Cara has been amazing at guiding me through the process and helping me create a lifestyle diet so that this can be the gift that keeps on giving. I feel better than ever.”
Our Compounded Semaglutide Weight Loss Program: Frequently Asked Questions
Compounded Semaglutide sodium or semaglutide acetate is a once a week, subcutaneous injectable medication that has been shown to reduce appetite and suppress cravings. When used in combination with diet and exercise, this form of Semaglutide can help with blood sugar control in type 2 diabetics. It has also been shown to help with weight loss. Semaglutide belongs to a class of medications – glucagon-like peptide-1 (GLP-1) agonists, which mimic the hormone GLP-1 to lower blood sugar levels after eating. Compounded Semaglutide sodium or semaglutide acetate is a different form of Semaglutide than the one used in the pharmaceutically branded products by Novo Nordisk. There is a significant amount of data showing the safety and effectiveness of compounded Semaglutide as a medication for weight loss.
No, Semaglutide is not a type of insulin or a substitute for insulin.
Glucagon-like peptide 1 (GLP-1) is a hormone that causes huge effects on the regulation of blood sugar by stimulating glucose-dependent insulin secretion. Insulin is a hormone that promotes sugar uptake by the cells, stores sugar as glycogen, promotes the building of fat, and signals the body to build skeletal muscle. In addition, GLP-1 inhibits glucagon release (which slows down the release of sugar into the blood so that you burn more fat), slows down gastric emptying (makes you feel full), and lowers the desire for food intake (because you feel full).
No, Semaglutide is not a stimulant.
GLP-1 agonists like Semaglutide help to control your blood sugar. Those taking it also tend to lose weight. GLP-1, the key hormone involved, slows down stomach emptying and in addition, can stimulate your pancreas to release insulin. Semaglutide also blocks a hormone that causes your liver to release sugar (glucagon). Together, these functions can help you feel less hungry, causing you to eat less food and lose more weight.
Yes, it is believed and clinically seen that Semaglutide sodium and semagluitde acetate can help curb your appetite. In addition to slowing gastric emptying to make you feel full for longer, GLP-1 also plays a direct role with appetite.
With Semaglutide sodium or Semaglutide acetate, you will slowly work your way up to the target dose at which time you will see the most amount of weight loss. We prefer to keep the max dose at 1.75 mg to avoid potential side effects. Clinically, we have found semaglutide sodium and semaglutide acetate to be highly effective in our patient population. It is important to keep in mind that weight loss can take time. You will see the best results when you are using it in combination with a healthy diet and exercise. Sometimes the medication may not work for you, or you may not be able to tolerate it. Most do well.
We monitor our patients on Semagluitde sodium or Semaglutide acetate very closely in our medically supervised weight loss program. The course will be different for every unique individual.
In our clinical experience, we have found Semaglutide to be safe and effective, However, Semaglutide acetate and semaglutide sodium have not been tested or approved by the FDA. The form of Semaglutide made by Novo Nordisk is different and is the only one with FDA testing and approval. Pharmaceutically branded forms of Semaglutide have a box warning about thyroid C-cell tumors occurring in rodents (with unknown risk in humans), and Semaglutide shouldn’t be used if you or your family have a history of certain thyroid cancers. Semaglutide should not be used in people with type-1 diabetes or a history of pancreatitis. Semaglutide should be used cautiously for people on other blood sugar lowering medications. It should also not be used if you are under 18, pregnant, trying to get pregnant or breastfeeding.
At The Natural Path, we do not bill any insurance companies – fee for service only.
We do not use the pharmaceutically branded forms of Semaglutide or the patented molecule of Semaglutide in our clinic. We use the form of semaglutide sodium or semaglutide acetate made in compouding pharmacies. Novo Nordisk’s form is patented at this time. We can only use the compounded forms of Semaglutide at this time due to the fact that the pharmaceutically branded forms are on the “shortage list.”
The common side effects are nausea, vomiting, constipation, diarrhea, and stomach pain. It is also advised to avoid or reduce alcohol consumption on the program.